Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

Tandlæge Sofie Lindberg ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Bankruptcy risk for industry   0.5% 0.5% 0.5% 0.5% 0.5% 0.5% 0.5% 0.5%   Bankruptcy risk   1.6% 3.2% 2.9% 3.8% 2.2% 2.5% 13.1% 12.8%   Credit score (0-100)   76 57 58 49 65 61 18 18   Credit rating   A BBB BBB BBB BBB BBB BB BB   Credit limit (kDKK)   1.7 0.0 -0.0 -0.0 0.0 0.0 -0.0 -0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   1,513 1,302 1,840 2,343 2,809 2,227 0.0 0.0   EBITDA   433 -154 -72.0 89.6 459 741 0.0 0.0   EBIT   376 -233 -268 -130 278 533 0.0 0.0   Pre-tax profit (PTP)   361.3 -242.8 -310.4 -174.2 214.8 470.6 0.0 0.0   Net earnings   322.6 -189.5 -242.1 -139.5 168.2 366.9 0.0 0.0   Pre-tax profit without non-rec. items   361 -243 -297 -148 259 510 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Tangible assets total   66.0 27.6 594 497 424 526 0.0 0.0   Shareholders equity total   318 128 -646 -785 -617 -250 -291 -291   Interest-bearing liabilities   230 314 1,781 1,330 1,162 778 349 349   Balance sheet total (assets)   770 800 1,676 1,278 1,050 868 58.4 58.4   Net Debt   183 289 1,613 1,273 1,158 753 349 349     See the entire balance sheet 1000.0 Volume  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   1,513 1,302 1,840 2,343 2,809 2,227 0.0 0.0   Gross profit growth   -23.9% -13.9% 41.2% 27.4% 19.9% -20.7% -100.0% 0.0%   Employees   3 3 4 4 3 2 0 0   Employee growth %   0.0% 0.0% 33.3% 0.0% -25.0% -33.3% -100.0% 0.0%   Employee expenses   -1,079.3 -1,456.7 -1,911.5 -2,253.8 -2,349.4 -1,485.9 0.0 0.0   Balance sheet total (assets)   770 800 1,676 1,278 1,050 868 58 58   Balance sheet change%   -10.2% 3.9% 109.5% -23.8% -17.8% -17.3% -93.3% 0.0%   Added value   1,512.8 1,302.5 1,839.5 2,343.4 2,847.6 2,226.8 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -243 -157 331 -357 -295 -145 -526 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   2.0 -1.0 -2.0 -3.0 1.0 2.0 0.0 0.0   1000.0 Profitability  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   24.9% -17.9% -14.5% -5.6% 9.9% 24.0% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   46.3% -29.6% -17.1% -6.0% 15.0% 38.4% 0.0% 0.0%   ROI %   67.6% -44.9% -22.5% -7.1% 18.4% 50.5% 0.0% 0.0%   ROE %   54.9% -85.0% -26.8% -9.4% 14.5% 38.3% 0.0% 0.0%   1000.0 Solidity  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Equity ratio %   41.3% 16.0% -27.8% -38.1% -37.0% -22.3% -83.3% -83.3%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   42.2% -187.2% -2,239.4% 1,420.9% 252.0% 101.6% 0.0% 0.0%   Gearing %   72.3% 245.3% -275.9% -169.4% -188.4% -311.3% -120.1% -120.1%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   4.3% 4.0% 2.9% 1.1% 1.6% 2.6% 0.0% 0.0%   1000.0 Liquidity  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Quick Ratio   1.1 0.9 0.4 0.3 0.3 0.3 0.0 0.0   Current Ratio   1.1 0.9 0.4 0.3 0.3 0.3 0.0 0.0   Cash and cash equivalent   46.8 25.6 168.3 56.3 4.2 25.1 0.0 0.0   1000.0 Capital use efficiency  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   26.1 -97.2 -1,284.8 -1,278.3 -1,023.4 -773.5 -174.6 -174.6   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   504 434 460 586 949 1,113 0 0   Employee expenses / employee   -360 -486 -478 -563 -783 -743 0 0   EBITDA / employee   144 -51 -18 22 153 370 0 0   EBIT / employee   125 -78 -67 -33 93 267 0 0   Net earnings / employee   108 -63 -61 -35 56 183 0 0